[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2059 Introduced in House (IH)]
107th CONGRESS
1st Session
H. R. 2059
To amend the Public Health Service Act to provide for human embryonic
stem cell generation and research.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 5, 2001
Mr. McDermott introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to provide for human embryonic
stem cell generation and research.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Stem Cell Research Act of 2001''.
SEC. 2. HUMAN EMBRYONIC STEM CELL GENERATION AND RESEARCH.
Part H of the Title IV of the Public Health Service Act (42 U.S.C.
289 et seq.) is amended by inserting after section 498B the following:
``SEC. 498C. HUMAN EMBRYONIC STEM CELL GENERATION AND RESEARCH.
``(a) In General.--Notwithstanding any other provision of law, the
Secretary may only conduct, support, or fund research on human embryos
for the purpose of generating embryonic stem cells and utilizing stem
cells that have been derived from embryos in accordance with this
section.
``(b) Sources of Embryonic Stem Cells.--For purposes of carrying
out research under subsection (a), the human embryonic stem cells
involved shall be derived only from embryos that have been donated from
in-vitro fertilization clinics after compliance with the following:
``(1) Prior to the consideration of embryo donation and
through consultation with the progenitors, it is determined
that the embryos will never be implanted in a woman and would
otherwise be discarded.
``(2) The embryos are donated with the written informed
consent of the progenitors.
``(c) Restrictions.--
``(1) In general.--The following restriction shall apply
with respect to human embryonic stem cell research conducted or
supported under subsection (a):
``(A) The research involved shall not result in the
creation of human embryos.
``(B) The research involved shall not result in the
reproductive cloning of a human being.
``(2) Prohibition.--
``(A) In general.--It shall be unlawful for any
person receiving Federal funds to knowingly acquire,
receive, or otherwise transfer any human embryos for
valuable consideration if the acquisition, receipt, or
transfer affects interstate commerce.
``(B) Definition.--In subparagraph (A), the term
`valuable consideration' does not include reasonable
payments associated with transportation,
transplantation, processing, preservation, quality
control, or storage.
``(d) Guidelines.--The Secretary, in conjunction with the Director
of the National Institutes of Health, shall issue guidelines that
expand on the rules governing human embryonic stem cell research (as in
effect on the date of enactment of this section) to include rules that
govern the derivation of stem cells from donated embryos under this
section.
``(e) Reporting Requirements.--The Secretary shall annually prepare
and submit to the appropriate committees of Congress a report
describing the activities carried out under this section during the
preceding fiscal year, and including a description of whether and to
what extent research under subsection (a) has been conducted in
accordance with this section.''.
<all>